KRMD
Price
$2.94
Change
-$0.02 (-0.68%)
Updated
Oct 12, 11:00 AM (EDT)
Capitalization
141.29M
30 days until earnings call
Intraday BUY SELL Signals
PDEX
Price
$63.60
Change
+$1.11 (+1.78%)
Updated
Oct 12, 11:02 AM (EDT)
Capitalization
229.42M
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KRMD vs PDEX

KRMD vs PDEX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KRMD vs. PDEX commentary
Oct 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRMD is a Buy and PDEX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
KRMD vs PDEX: Fundamental Ratings
KRMD
PDEX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
10053
SMR RATING
1..100
9431
PRICE GROWTH RATING
1..100
8040
P/E GROWTH RATING
1..100
3414
SEASONALITY SCORE
1..100
8535

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDEX's Valuation (59) in the Medical Or Nursing Services industry is in the same range as KRMD (89) in the null industry. This means that PDEX’s stock grew similarly to KRMD’s over the last 12 months.

PDEX's Profit vs Risk Rating (53) in the Medical Or Nursing Services industry is somewhat better than the same rating for KRMD (100) in the null industry. This means that PDEX’s stock grew somewhat faster than KRMD’s over the last 12 months.

PDEX's SMR Rating (31) in the Medical Or Nursing Services industry is somewhat better than the same rating for KRMD (94) in the null industry. This means that PDEX’s stock grew somewhat faster than KRMD’s over the last 12 months.

PDEX's Price Growth Rating (40) in the Medical Or Nursing Services industry is somewhat better than the same rating for KRMD (80) in the null industry. This means that PDEX’s stock grew somewhat faster than KRMD’s over the last 12 months.

PDEX's P/E Growth Rating (14) in the Medical Or Nursing Services industry is in the same range as KRMD (34) in the null industry. This means that PDEX’s stock grew similarly to KRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRMDPDEX
RSI
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
69%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 25 days ago
79%
Bullish Trend 27 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
COMPARISON
Comparison
Oct 12, 2026
Stock price -- (KRMD: $2.96 vs. PDEX: $62.49)
Brand notoriety: KRMD and PDEX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KRMD: 69% vs. PDEX: 48%
Market capitalization -- KRMD: $141.29M vs. PDEX: $229.42M
KRMD [@Pharmaceuticals: Other] is valued at $141.29M. PDEX’s [@Pharmaceuticals: Other] market capitalization is $229.42M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $146.54B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRMD’s FA Score shows that 0 FA rating(s) are green while PDEX’s FA Score has 2 green FA rating(s).

  • KRMD’s FA Score: 0 green, 5 red.
  • PDEX’s FA Score: 2 green, 3 red.
According to our system of comparison, PDEX is a better buy in the long-term than KRMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRMD’s TA Score shows that 4 TA indicator(s) are bullish while PDEX’s TA Score has 3 bullish TA indicator(s).

  • KRMD’s TA Score: 4 bullish, 4 bearish.
  • PDEX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, KRMD is a better buy in the short-term than PDEX.

Price Growth

KRMD (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while PDEX (@Pharmaceuticals: Other) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -3.43%, and the average quarterly price growth was +14.05%.

Reported Earning Dates

KRMD is expected to report earnings on Nov 11, 2026.

PDEX is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
KRMD
Daily Signal:
Gain/Loss:
PDEX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HIMU45.440.25
+0.55%
iShares High Yield Muni Active ETF (HIMU)
JULP33.750.18
+0.54%
PGIM S&P 500 Buffer 12 ETF - July (JULP)
JHS10.160.04
+0.44%
John Hancock Income Securities Trust Capital Stock
GMAY44.380.12
+0.27%
FT Vest U.S. Equity Moderate Buffer ETF - May (GMAY)
UJB73.77N/A
N/A
ProShares Ultra High Yield (UJB)

KRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRMD has been loosely correlated with QDEL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KRMD jumps, then QDEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRMD
1D Price
Change %
KRMD100%
-1.33%
QDEL - KRMD
40%
Loosely correlated
+8.14%
A - KRMD
40%
Loosely correlated
+1.41%
CLPT - KRMD
39%
Loosely correlated
-0.10%
BIO - KRMD
38%
Loosely correlated
+1.60%
NVST - KRMD
35%
Loosely correlated
+1.23%
More

PDEX and

Correlation & Price change

A.I.dvisor tells us that PDEX and KRMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and KRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
+0.45%
KRMD - PDEX
25%
Poorly correlated
-1.33%
TCMD - PDEX
24%
Poorly correlated
+1.45%
PRE - PDEX
23%
Poorly correlated
-0.73%
WAT - PDEX
23%
Poorly correlated
+1.08%
GKOS - PDEX
23%
Poorly correlated
+2.73%
More